Ken Mariash, CEO of Sinaptica Therapeutics, which is developing a personalized closed-loop neuromodulation therapy for Alzheimer’s disease, gave a double award-winning presentation at the Octane Medical Innovation Forum in Irvine, CA, on 8 October.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?